Use of Ferritin-Based Metal-Encapsulated Nanocarriers as Anticancer Agents
暂无分享,去创建一个
Gianni Colotti | Giulia Guarguaglini | Luciana Mosca | Elisabetta Falvo | Pierpaolo Ceci | Elena Poser | Ilaria Genovese | G. Guarguaglini | L. Mosca | G. Colotti | E. Poser | E. Falvo | P. Ceci | Ilaria Genovese
[1] J. Connor,et al. Consequences of expressing mutants of the hemochromatosis gene (HFE) into a human neuronal cell line lacking endogenous HFE , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[2] C. Beaumont,et al. Early Embryonic Lethality of H Ferritin Gene Deletion in Mice* , 2000, The Journal of Biological Chemistry.
[3] J. Connor,et al. Receptor‐mediated transcytosis of transferrin across the blood‐brain barrier , 1987, Journal of neuroscience research.
[4] Mauri A Kostiainen,et al. Electrostatic assembly of binary nanoparticle superlattices using protein cages. , 2013, Nature nanotechnology.
[5] M. Yamamoto,et al. In vitro cytotoxicities and in vivo distribution of transferrin-platinum(II) complex. , 1995, Journal of pharmaceutical sciences.
[6] R. Kalaria. Brain Microvasculature in Aging , 1994, Neurobiology of Aging.
[7] C. Leonetti,et al. Antibody-drug conjugates: targeting melanoma with cisplatin encapsulated in protein-cage nanoparticles based on human ferritin. , 2013, Nanoscale.
[8] A. Boffi,et al. In Vivo Targeting of Cutaneous Melanoma Using an Melanoma Stimulating Hormone-Engineered Human Protein Cage with Fluorophore and Magnetic Resonance Imaging Tracers. , 2015, Journal of biomedical nanotechnology.
[9] T. Waseem,et al. Ferritin, a protein containing iron nanoparticles, induces reactive oxygen species formation and inhibits glutamate uptake in rat brain synaptosomes , 2008, Brain Research.
[10] M. Büchler,et al. Transferrin receptor is a marker of malignant phenotype in human pancreatic cancer and in neuroendocrine carcinoma of the pancreas. , 2004, European journal of cancer.
[11] W. Jefferies,et al. Transferrin receptor on endothelium of brain capillaries , 1984, Nature.
[12] M. Hande,et al. Anti-proliferative activity of silver nanoparticles , 2009, BMC Cell Biology.
[13] J. Benoit,et al. Transferrin Adsorption onto PLGA Nanoparticles Governs Their Interaction with Biological Systems from Blood Circulation to Brain Cancer Cells , 2011, Pharmaceutical Research.
[14] M. Biffoni,et al. Transferrin receptor 2 is frequently expressed in human cancer cell lines. , 2007, Blood cells, molecules & diseases.
[15] L. Tei,et al. Magnetic resonance visualization of tumor angiogenesis by targeting neural cell adhesion molecules with the highly sensitive gadolinium-loaded apoferritin probe. , 2006, Cancer research.
[16] N. Elad,et al. Improved Doxorubicin Encapsulation and Pharmacokinetics of Ferritin-Fusion Protein Nanocarriers Bearing Proline, Serine, and Alanine Elements. , 2016, Biomacromolecules.
[17] G. Marcucci,et al. Efficient delivery of a Bcl-2-specific antisense oligodeoxyribonucleotide (G3139) via transferrin receptor-targeted liposomes. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[18] Xiaogang Pan,et al. Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil. , 2007, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.
[19] A. Boffi,et al. Metals and metal derivatives in medicine. , 2013, Mini reviews in medicinal chemistry.
[20] Seong-Cheol Park,et al. Encapsulation of paclitaxel into lauric acid-O-carboxymethyl chitosan-transferrin micelles for hydrophobic drug delivery and site-specific targeted delivery. , 2013, International journal of pharmaceutics.
[21] W. Seaman,et al. Binding and uptake of H-ferritin are mediated by human transferrin receptor-1 , 2010, Proceedings of the National Academy of Sciences.
[22] L. Donini,et al. Neuroprotective Effect of Brassica oleracea Sprouts Crude Juice in a Cellular Model of Alzheimer's Disease , 2015, Oxidative medicine and cellular longevity.
[23] R. MacGillivray,et al. Genetically engineering transferrin to improve its in vitro ability to deliver cytotoxins. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[24] M. Walsh,et al. Transferrin receptor expression by human bladder transitional cell carcinomas , 1987, Urological research.
[25] A. Albertini,et al. The role of the L-chain in ferritin iron incorporation. Studies of homo and heteropolymers. , 1994, Journal of molecular biology.
[26] Fan Zhang,et al. Chimeric ferritin nanocages for multiple function loading and multimodal imaging. , 2011, Nano letters.
[27] E. Shusta,et al. Targeting receptor-mediated transport for delivery of biologics across the blood-brain barrier. , 2015, Annual review of pharmacology and toxicology.
[28] I. Orienti,et al. Sodium Ascorbate induces apoptosis in neuroblastoma cell lines by interfering with iron uptake , 2007, Molecular Cancer.
[29] Jan C M van Hest,et al. Functionalization of protein-based nanocages for drug delivery applications. , 2014, Nanoscale.
[30] Alexander Böker,et al. Ferritin: a versatile building block for bionanotechnology. , 2015, Chemical reviews.
[31] M. Noguchi,et al. Transferrin receptor expression in adenocarcinoma of the lung as a histopathologic indicator of prognosis. , 1990, Chest.
[32] A. Ilari,et al. Silver ion incorporation and nanoparticle formation inside the cavity of Pyrococcus furiosus ferritin: structural and size-distribution analyses. , 2010, Journal of the American Chemical Society.
[33] M. Young,et al. Intracellular Distribution of Macrophage Targeting Ferritin–Iron Oxide Nanocomposite , 2009 .
[34] Dongling Yang,et al. H-ferritin–nanocaged doxorubicin nanoparticles specifically target and kill tumors with a single-dose injection , 2014, Proceedings of the National Academy of Sciences.
[35] Q. Lan,et al. Transferrin-modified Doxorubicin-loaded biodegradable nanoparticles exhibit enhanced efficacy in treating brain glioma-bearing rats. , 2013, Cancer biotherapy & radiopharmaceuticals.
[36] C. Innocenti,et al. A smart platform for hyperthermia application in cancer treatment: cobalt-doped ferrite nanoparticles mineralized in human ferritin cages. , 2014, ACS nano.
[37] P. Harrison,et al. Influence of site-directed modifications on the formation of iron cores in ferritin. , 1991, Journal of molecular biology.
[38] L. Pieroni,et al. New insights into neuroblastoma cisplatin resistance: a comparative proteomic and meta-mining investigation. , 2011, Journal of proteome research.
[39] T. Coccini,et al. Assessment of Cellular Responses after Short- and Long-Term Exposure to Silver Nanoparticles in Human Neuroblastoma (SH-SY5Y) and Astrocytoma (D384) Cells , 2014, TheScientificWorldJournal.
[40] Suzy V. Torti,et al. Mouse brains deficient in H‐ferritin have normal iron concentration but a protein profile of iron deficiency and increased evidence of oxidative stress , 2003, Journal of neuroscience research.
[41] N. Kadowaki,et al. H-Ferritin Is Preferentially Incorporated by Human Erythroid Cells through Transferrin Receptor 1 in a Threshold-Dependent Manner , 2015, PloS one.
[42] Tom C. Karagiannis,et al. Transferrin Receptor-Mediated Endocytosis: A Useful Target for Cancer Therapy , 2014, The Journal of Membrane Biology.
[43] C. Innocenti,et al. Synthesis of iron oxide nanoparticles in Listeria innocua Dps (DNA-binding protein from starved cells): a study with the wild-type protein and a catalytic centre mutant. , 2010, Chemistry.
[44] M. Bellini,et al. Protein nanocages for self-triggered nuclear delivery of DNA-targeted chemotherapeutics in Cancer Cells. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[45] J. Connor,et al. Transferrin is required for normal distribution of 59Fe and 54Mn in mouse brain , 1999, Journal of the Neurological Sciences.
[46] S. Xie,et al. Cisplatin regulates SH-SY5Y cell growth through downregulation of BDNF via miR-16. , 2013, Oncology reports.
[47] M. Dehouck,et al. Receptor-mediated transcytosis of transferrin through blood-brain barrier endothelial cells. , 1996, The American journal of physiology.
[48] N. Žarković,et al. Altered iron metabolism, transferrin receptor 1 and ferritin in patients with colon cancer. , 2006, Cancer letters.
[49] R. Jain,et al. Delivering nanomedicine to solid tumors , 2010, Nature Reviews Clinical Oncology.
[50] M. Ferrari,et al. Engineering multi-stage nanovectors for controlled degradation and tunable release kinetics. , 2013, Biomaterials.
[51] M. Gramiccia,et al. Inhibitory Effect of Silver Nanoparticles on Trypanothione Reductase Activity and Leishmania infantum Proliferation. , 2011, ACS medicinal chemistry letters.
[52] J. Connor,et al. Ferritin: a novel mechanism for delivery of iron to the brain and other organs. , 2007, American journal of physiology. Cell physiology.
[53] P. Harrison,et al. The ferritins: molecular properties, iron storage function and cellular regulation. , 1996, Biochimica et biophysica acta.
[54] D. Mason,et al. Transferrin receptors in human tissues: their distribution and possible clinical relevance. , 1983, Journal of clinical pathology.
[55] B. Nemesure,et al. Differential Expression of Transferrin Receptor (TfR) in a Spectrum of Normal to Malignant Breast Tissues: Implications for In Situ and Invasive Carcinoma , 2011, Applied immunohistochemistry & molecular morphology : AIMM.
[56] E. Chiancone,et al. Iron and proteins for iron storage and detoxification , 2004, Biometals.